Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: ‘It’s The Second-Largest Semaglutide Market In The World,’ Says Sandoz CEO Richard Saynor – Sandoz Group (OTC:SDZNY), Novo Nordisk (NYSE:NVO) – Benzinga
Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: ‘It’s The Second-Largest Semaglutide Market In The World,’ Says Sandoz CEO Richard Saynor – Sandoz Group (OTC:SDZNY), Novo Nordisk (NYSE:NVO) Benzinga